Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
Kline
S S
SS
Department of Pharmacy, Medical College of Ohio, Toledo.
Mauro
L S
LS
Scala-Barnett
D M
DM
Zick
D
D
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002423:Cause of Death; D003402:Creatine Kinase / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome; D012640:Seizures / Q000139:chemically induced; D012701:Serotonin / Q000502:physiology*; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D014364:Tryptophan; D003402:Creatine Kinase